Cardiovascular Monitoring for People With Cardiovascular Disease and Schizophrenia (SMC)
-
The percentage of patients 18 – 64 years of age with schizophrenia and cardiovascular disease, who had an LDL-C test during the measurement year.
CBE ID1933